Skip to main content
https://www.highperformancecpmgate.com/rgeesizw1?key=a9d7b2ab045c91688419e8e18a006621

UK researchers develop new low-cost, rapid COVID-19 test that could even be used at home

A new type of test developed by UK researchers from the Brunel University London, Lancaster University and the University of Surrey can provide COVID-19 detection in as little as 30 minutes, using hand-held hardware that costs as little as £100 (around $120 USD) with individual swab sample kits that cost around $5 per person. The test is based on existing technology that has been used in the Philippines for testing viral spread in chickens, but it’s been adapted by researchers for use with COVID-19 in humans, and the team is now working on ramping mass production.

This test would obviously need approval by local health regulatory bodies like the FDA before it goes into active use in any specific geography, but the researchers behind the project are “confident it will respond well,” and say they could even make it available for use “within a few weeks.” The hardware itself is battery-operated and connects to a smartphone application to display diagnostic results and works with nasal or throat swabs, without requiring that samples be round-tripped to a lab.

There are other tests already approved for use that use similar methods for on-site testing, including kits and machines from Cepheid and Mesa Biotech. These require expensive dedicated table-top micro-labs, however, which is installed in dedicated healthcare facilities including hospitals. This test from UK scientists has the advantage of running on inexpensive hardware, with testing capabilities for up to six people at once, which can be deployed in doctor’s offices, hospitals and even potentially workplaces and homes for truly widespread, accessible testing.

Some frontline, rapid results tests are already in use in the EU and China, but these are generally serological tests that rely on the presence of antibodies, whereas this group’s diagnostics are molecular, so it can detect the presence of viral DNA even before antibodies are present. This equipment could even potentially be used to detect the virus in asymptomatic individuals who are self-isolating at home, the group notes, which would go a long way to scoping out the portion of the population that’s not currently a priority for other testing methods, but that could provide valuable insight into the true extend of silent, community-based transmission of the coronavirus.

Comments

Popular posts from this blog

Uber co-founder Garrett Camp steps back from board director role

Uber co-founder Garrett Camp is relinquishing his role as a board director and switching to board observer — where he says he’ll focus on product strategy for the ride hailing giant. Camp made the announcement in a short Medium post in which he writes of his decade at Uber: “I’ve learned a lot, and realized that I’m most helpful when focused on product strategy & design, and this is where I’d like to focus going forward.” “I will continue to work with Dara [Khosrowshahi, Uber CEO] and the product and technology leadership teams to brainstorm new ideas, iterate on plans and designs, and continue to innovate at scale,” he adds. “We have a strong and diverse team in place, and I’m confident everyone will navigate well during these turbulent times.” The Canadian billionaire entrepreneur signs off by saying he’s looking forward to helping Uber “brainstorm the next big idea”. Camp hasn’t been short of ideas over his career in tech. He’s the co-founder of the web 2.0 recommendatio...

Leading VCs discuss how COVID-19 has impacted the world of digital health

In December 2019, Extra Crunch spoke to a group of investors leading the charge in health tech to discuss where they saw the most opportunity in the space leading into 2020 . At the time, respondents highlighted startups in digital therapeutics, telehealth and mental health that were improving medical practitioner efficiency or streamlining the distribution of care, amongst a variety of other digital health markets that were garnering the most attention. Where top VCs are investing in digital health In the months since, the COVID-19 crisis has debilitated national healthcare systems and the global economy. Weaknesses in healthcare systems have become clearer than ever, while startups and capital providers have struggled to operate while wide swaths of the market effectively shut down. Given significant volatility and the rapid changes seen in the worlds of healthcare, venture and startups broadly, we wanted to understand which inefficiencies might have been brought to light, w...

News-reading app Flipboard expands local coverage, including coronavirus updates, to 12 more U.S. metros

Earlier this year, personalized news aggregation app Flipboard expanded into local news . The feature brought local news, sports, real estate, weather, transportation news and more to 23 cities across the U.S. Today, Flipboard is bringing local news to 12 more U.S. metros and is adding critical coronavirus local coverage to all of the 35 supported locales. The 12 new metros include the following:  Baltimore, Charlotte, Cleveland, Detroit, Indianapolis, Nashville, Pittsburgh, Orlando, Raleigh, Salt Lake City, St. Louis, and Tampa Bay. They join the 23 cities that were already supported:  Atlanta, Austin, Boston, Chicago, Dallas, Denver, Houston, Las Vegas, Los Angeles, Miami, Minneapolis-St. Paul, New Orleans, New York City, Philadelphia, Phoenix, Portland, Sacramento, San Diego, San Francisco Bay Area, Seattle, Toronto, Vancouver and Washington, D.C. To offer local news in its app, Flipboard works with area partners, big and small, like The Plain Dealer’s Cleveland.com , ...